A mixed-method analysis of oncologist-patient communications about immune checkpoint inhibitors (COACH)
During in-clinic discussions of ICI therapy, oncologists provided detailed information about immunology and cancer, often aided by metaphors. Probabilities were commonly used to describe the likelihood of toxicities and benefits. The amount of information provided by the oncologists aligned with the patients' preference for detailed information about their cancer treatments.
Authors
- Scott S. Tykodi (ORCID: https://orcid.org/0000-0002-0399-0965)
- Petros D. Grivas (ORCID: https://orcid.org/0000-0003-3965-3394)
- John A. Thompson (ORCID: https://orcid.org/0000-0002-0872-7306)
- Shailender Bhatia (ORCID: https://orcid.org/0000-0002-3816-2238)
- Anissa Chan (ORCID: https://orcid.org/0009-0002-3381-8960)
- Evan Hall (ORCID: https://orcid.org/0000-0002-0305-7745)
- Julia Majovski
- Wenwen Chen (ORCID: https://orcid.org/0000-0002-9021-1674)
- Joshua Veatch (ORCID: https://orcid.org/0000-0002-6543-9255)
- Sumit Shah (ORCID: https://orcid.org/0000-0001-9479-2333)
- Sylvia Lee (ORCID: https://orcid.org/0009-0002-3059-4412)
- Lidia Schapira (ORCID: https://orcid.org/0000-0002-3298-9103)
Institutions
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- Stanford University (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1093/oncolo/oyaf064
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Melanoma Research Alliance
- Fred Hutchinson Cancer Research Center
- University of Washington